The global market for Apheresis Equipment is estimated at US$2.7 Billion in 2023 and is projected to reach US$4.6 Billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the apheresis equipment market is driven by several factors that underscore the convergence of technology, healthcare needs, and demographic shifts. Increasing prevalence of chronic diseases globally, which often require blood component therapies, directly contributes to the demand for more sophisticated apheresis equipment. The technological advancements that enhance machine efficiency and patient safety also play a significant role, as they meet the stringent standards of modern healthcare practices. Furthermore, there is a growing awareness and acceptance of apheresis as a preferred method for collecting high-quality blood components necessary for treating complex conditions.
This acceptance is further buoyed by the healthcare shift towards personalized medicine, where treatments are tailored to the specific needs of patients, often requiring components collected via apheresis. Lastly, the expansion of healthcare infrastructure across emerging markets and the increasing investments in blood donation programs and specialty clinics are pivotal in driving the adoption of advanced apheresis equipment. These factors, coupled with the rising number of elderly populations at risk for chronic diseases, ensure sustained growth and innovation in the sector, meeting both current and future healthcare challenges.
The growth in the apheresis equipment market is driven by several factors that underscore the convergence of technology, healthcare needs, and demographic shifts. Increasing prevalence of chronic diseases globally, which often require blood component therapies, directly contributes to the demand for more sophisticated apheresis equipment. The technological advancements that enhance machine efficiency and patient safety also play a significant role, as they meet the stringent standards of modern healthcare practices. Furthermore, there is a growing awareness and acceptance of apheresis as a preferred method for collecting high-quality blood components necessary for treating complex conditions.
This acceptance is further buoyed by the healthcare shift towards personalized medicine, where treatments are tailored to the specific needs of patients, often requiring components collected via apheresis. Lastly, the expansion of healthcare infrastructure across emerging markets and the increasing investments in blood donation programs and specialty clinics are pivotal in driving the adoption of advanced apheresis equipment. These factors, coupled with the rising number of elderly populations at risk for chronic diseases, ensure sustained growth and innovation in the sector, meeting both current and future healthcare challenges.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Disposable Apheresis Kits segment, which is expected to reach US$3.1 Billion by 2030 with a CAGR of a 8.2%. The Plasma & Component Separator segment is also set to grow at 7.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $929.7 Million in 2023, and China, forecasted to grow at an impressive 11.3% CAGR to reach $548.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Apheresis Equipment Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Apheresis Equipment Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Apheresis Equipment Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as B. Braun Melsungen AG, Kaneka Corporation, B. Braun Medical, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 24 Featured):
- B. Braun Melsungen AG
- Kaneka Corporation
- B. Braun Medical, Inc.
- Fresenius Kabi AG
- Miltenyi Biotec GmbH
- Fresenius SE & Co. KGaA
- Kawasumi Laboratories, Inc.
- Nikkiso Co., Ltd.
- Fresenius Medical Care AG & Co. KgaA
- Asahi Kasei Medical Co., Ltd.
- Haemonetics Corporation
- HemaCare Corporation
- Mallinckrodt Pharmaceuticals
- Fresenius Kabi USA
- Aferetica Srl
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
TECHNOLOGY OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- B. Braun Melsungen AG
- Kaneka Corporation
- B. Braun Medical, Inc.
- Fresenius Kabi AG
- Miltenyi Biotec GmbH
- Fresenius SE & Co. KGaA
- Kawasumi Laboratories, Inc.
- Nikkiso Co., Ltd.
- Fresenius Medical Care AG & Co. KgaA
- Asahi Kasei Medical Co., Ltd.
- Haemonetics Corporation
- HemaCare Corporation
- Mallinckrodt Pharmaceuticals
- Fresenius Kabi USA
- Aferetica Srl
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 604 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 2.7 Billion |
Forecasted Market Value ( USD | $ 4.6 Billion |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |
No. of Companies Mentioned | 15 |